MUSCLE INVASIVE BLADDER CANCER (MIBC)
Clinical trials for MUSCLE INVASIVE BLADDER CANCER (MIBC) explained in plain language.
Never miss a new study
Get alerted when new MUSCLE INVASIVE BLADDER CANCER (MIBC) trials appear
Sign up with your email to follow new studies for MUSCLE INVASIVE BLADDER CANCER (MIBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to save bladders in HER2-positive cancer patients
Disease control Recruiting nowThis study tests a combination of two drugs (zanidatamab and tislelizumab) plus chemotherapy in 25 people with HER2-positive muscle-invasive bladder cancer. The goal is to shrink the tumor enough to avoid removing the bladder. Participants receive treatment before any surgery, an…
Matched conditions: MUSCLE INVASIVE BLADDER CANCER (MIBC)
Phase: PHASE2 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated May 26, 2026 03:32 UTC
-
New 'Smart Bomb' therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a two-part approach for people with advanced solid tumors that cannot be removed by surgery. First, a radioactive tracer helps doctors see the tumor on scans. Then, a therapeutic dose of radiation is given to destroy cancer cells. The goal is to find the safest a…
Matched conditions: MUSCLE INVASIVE BLADDER CANCER (MIBC)
Phase: PHASE1, PHASE2 • Sponsor: ITM Oncologics GmbH • Aim: Disease control
Last updated May 26, 2026 03:31 UTC
-
New study aims to find the best scan for bladder cancer staging
Diagnosis Recruiting nowThis study compares two types of scans—CT and MRI—to see which one is better at determining if bladder cancer has spread into the muscle layer. About 150 adults with newly diagnosed bladder cancer will receive both scans before surgery, and the results will be checked against tis…
Matched conditions: MUSCLE INVASIVE BLADDER CANCER (MIBC)
Sponsor: Oslo University Hospital • Aim: Diagnosis
Last updated May 26, 2026 03:35 UTC
-
Can a simple IV drip at home keep bladder cancer patients out of the hospital?
Symptom relief Recruiting nowThis study looks at whether giving patients IV fluids at home for four weeks after bladder cancer surgery can lower the chance of being readmitted to the hospital. About 130 adults having their bladder removed for cancer will be randomly assigned to either standard care or standa…
Matched conditions: MUSCLE INVASIVE BLADDER CANCER (MIBC)
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated May 26, 2026 02:48 UTC